Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) General Information

Description

UniverCyte technology patent located in Silicon Valley, California. The UniverCyte technology uses the tolerogenic molecule HLA-G, modified to be stably expressed on the cell-extracellular membrane, to confer low immune observability to the resulting cells.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • CA
  • United States
Primary Industry
Buildings and Property
Corporate Office
  • CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California)‘s full profile, request access.

Request a free trial

Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California)‘s full profile, request access.

Request a free trial

Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) FAQs

  • Where is Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) headquartered?

    Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) is headquartered in CA.

  • What industry is Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) in?

    Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California)’s primary industry is Buildings and Property.

  • Is Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) a private or public company?

    Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) is a Private company.

  • What is Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California)’s current revenue?

    The current revenue for Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) is .

  • Who are Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California)’s investors?

    Escape Therapeutics has invested in Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California).

  • When was Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) acquired?

    Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) was acquired on 16-Aug-2019.

  • Who acquired Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California)?

    Escape Therapeutics (UniverCyte Technology Patent in Silicon Valley, California) was acquired by AgeX Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process